In vitro and in vivo approaches to prevention and cure of T1D Peter A. Gottlieb Invited Commentary Pages: 77 - 78
Statin treatment of patients with diabetes George S. Eisenbarth Clinical Trials Report Pages: 81 - 81
Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications Yizhen XuZhiheng HeGeorge L. King OriginalPaper Pages: 91 - 97
Predicting type 1 diabetes Peter AchenbachEzio BonifacioAnette-G. Ziegler OriginalPaper Pages: 98 - 103
Regulatory T cells and type 1 diabetes Brygida C. BisikirskaKevan C. Herold OriginalPaper Pages: 104 - 109
Patient-reported assessments in diabetes care: Clinical and research applications Soren E. Skovlund OriginalPaper Pages: 115 - 123
Health-related quality of life among adults with diabetes Susan L. Norris OriginalPaper Pages: 124 - 130
Does bariatric surgery reduce obesity-related comorbidities? Richard B. HorensteinAlan R. Shuldiner Clinical Trials Report Pages: 133 - 135
Adiponectin: An adipokine linking adipocytes and type 2 diabetes in humans Kazuo HaraToshimasa YamauchiTakashi Kadowaki OriginalPaper Pages: 136 - 140
Nonobese diabetic mice and the genetics of diabetes susceptibility Edward H. Leiter OriginalPaper Pages: 141 - 148
The role of HNF4A variants in the risk of type 2 diabetes Karen L. MohlkeMichael Boehnke OriginalPaper Pages: 149 - 156